ES2003180A6 - Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento. - Google Patents

Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.

Info

Publication number
ES2003180A6
ES2003180A6 ES8603468A ES8603468A ES2003180A6 ES 2003180 A6 ES2003180 A6 ES 2003180A6 ES 8603468 A ES8603468 A ES 8603468A ES 8603468 A ES8603468 A ES 8603468A ES 2003180 A6 ES2003180 A6 ES 2003180A6
Authority
ES
Spain
Prior art keywords
polypeptide
proliferation
treatment
cells
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8603468A
Other languages
English (en)
Spanish (es)
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2003180A6 publication Critical patent/ES2003180A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ES8603468A 1985-12-20 1986-12-17 Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento. Expired ES2003180A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
ES2003180A6 true ES2003180A6 (es) 1988-10-16

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8603468A Expired ES2003180A6 (es) 1985-12-20 1986-12-17 Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.

Country Status (29)

Country Link
JP (1) JP2559035B2 (fi)
KR (1) KR920005920B1 (fi)
CN (1) CN1017626B (fi)
AT (1) AT400444B (fi)
AU (2) AU601168B2 (fi)
BE (1) BE905957A (fi)
CA (1) CA1340296C (fi)
CH (1) CH675727A5 (fi)
CY (1) CY1608A (fi)
DE (2) DE3643428A1 (fi)
DK (1) DK174094B1 (fi)
ES (1) ES2003180A6 (fi)
FI (1) FI91484C (fi)
FR (1) FR2597108B1 (fi)
GB (1) GB2185485B (fi)
GR (1) GR862936B (fi)
HK (1) HK65691A (fi)
HU (1) HU210694B (fi)
IE (1) IE59415B1 (fi)
IL (1) IL81017A (fi)
IT (1) IT1213428B (fi)
LU (1) LU86718A1 (fi)
NL (1) NL8603209A (fi)
NO (1) NO174556C (fi)
NZ (1) NZ218634A (fi)
OA (1) OA08494A (fi)
PT (1) PT83986B (fi)
SE (1) SE505059C2 (fi)
SG (1) SG60891G (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
DK615386A (da) 1987-06-21
LU86718A1 (fr) 1988-07-14
AU639048B2 (en) 1993-07-15
ATA340686A (de) 1995-05-15
SG60891G (en) 1991-08-23
CY1608A (en) 1992-04-03
DE3645095C2 (de) 1993-11-18
NO174556B (no) 1994-02-14
AU601168B2 (en) 1990-09-06
IT1213428B (it) 1989-12-20
AU6776590A (en) 1991-03-14
HUT43103A (en) 1987-09-28
FI91484B (fi) 1994-03-31
GB2185485A (en) 1987-07-22
SE8605459D0 (sv) 1986-12-18
GR862936B (en) 1987-10-28
SE505059C2 (sv) 1997-06-16
BE905957A (fr) 1987-06-17
DK174094B1 (da) 2002-06-10
NO865178L (no) 1987-06-22
PT83986A (en) 1987-01-01
CN86108955A (zh) 1987-12-02
DK615386D0 (da) 1986-12-18
HU210694B (en) 1995-06-28
CH675727A5 (fi) 1990-10-31
CA1340296C (en) 1998-12-29
KR920005920B1 (ko) 1992-07-24
IE863345L (en) 1987-06-20
GB2185485B (en) 1990-07-04
DE3643428A1 (de) 1987-09-24
AU6660886A (en) 1987-06-25
IL81017A (en) 1993-01-14
FR2597108A1 (fr) 1987-10-16
PT83986B (pt) 1989-07-31
IT8622787A0 (it) 1986-12-19
FR2597108B1 (fr) 1991-02-15
OA08494A (fr) 1988-07-29
CN1017626B (zh) 1992-07-29
SE8605459L (sv) 1987-06-21
DE3643428C2 (fi) 1990-08-23
FI91484C (fi) 1994-07-11
NZ218634A (en) 1991-06-25
JP2559035B2 (ja) 1996-11-27
HK65691A (en) 1991-08-23
NO865178D0 (no) 1986-12-19
NL8603209A (nl) 1987-07-16
GB8629997D0 (en) 1987-01-28
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
NO174556C (no) 1994-05-25
AT400444B (de) 1995-12-27
JPS62236498A (ja) 1987-10-16
KR870005645A (ko) 1987-07-06
IE59415B1 (en) 1994-02-23
IL81017A0 (en) 1987-03-31

Similar Documents

Publication Publication Date Title
IL157644A0 (en) Method for the purification of a protein preparation with erythropoietin activity
HUT41444A (en) Process for producing enzyme for alpha-amidisation
NZ218586A (en) Extraction of proteins by solubilisation
PH25251A (en) Preparation of polypeptides having human gamma interferon activity
ES2003180A6 (es) Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
AU7685087A (en) Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for fermentation processes
ES8302089A1 (es) Procedimiento para la preparacion microbiologica de un polipeplido que contiene total o parcialmente la secuencia de aminoacidos del interferon de fibrobastos humanos.
Penner et al. Fumarase: demonstration, separation, and hybridization of different subunit types
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
ES449890A1 (es) Procedimiento para el tratamiento de proteina de celula sim-ple.
Mastro et al. Iodination of plasma membrane proteins of BHK cells in different growth states
JPS6437291A (en) Human cytochrome c gene and use thereof
EP0257962A3 (en) Method for treatment of peripheral blood to improve lymphokine activated killer immunotherapy
EP0322084A3 (en) Tumor cell inhibition factor
AU7378087A (en) Interleukin-2 induced antineoplastic peptide
Hysmith et al. A novel phenotype-transforming protein isolated from intured aortic smooth muscle cells

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-12-17

FD1A Patent lapsed

Effective date: 20061218